| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UBN1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | RRAS | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | CYP4A22 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | ALDH16A1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | AP3M2 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | CTAGE5 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | RARS | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | SOCS4 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | MAP3K19 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | TRMT2B | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
